NIDA Directors Report - Complete Archives

• Full Reports
  • 2010: February, May, September
  • 2009: February, May, September
  • 2008: February, May, September
  • 2007: February, May, September
  • 2006: February, May, September
  • 2005: February, May, September
  • 2004: February, May, September
  • 2003: February, May, September
  • 2002: February, May September
  • 2001: February, May September
  • 2000: February, May September
  • 1999: February, May September
  • 1998: February, May September
  • 1997: February, May September
  • 1996: February, May September
  • 1995: February, May September
    
    
• Congressional Affairs Overview
  • 2010: February, May, September
  • 2009: February, May, September
  • 2008: February, May, September
  • 2007: February, May, September
  • 2006: February, May, September
  • 2005: February, May, September
  • 2004: February, May, September
  • 2003: February, May, September
  • 2002: February, May, September
  • 2001: February, May, September
  • 2000: February, May, September
  • 1999: February, May, September
  • 1998: February, May, September
  • 1997: February, May, September
  • 1996: February, May, September
  • 1995: February, May, September

Budget Information (Congressional Justification) Archives

• 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003 , 2002 , 2001

• Medications Development Research for Treatment of Amphetamine and Methamphetamine Addiction - Report to Congress (8/05)
• Substance Abuse and Mental Health Research and Services - Testimony before the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies - Committee on Appropriations - Statement of Nora D. Volkow, M.D. (4/27/05)
• Methamphetamine Abuse - Testimony before the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies - Committee on Appropriations - Statement of Nora D. Volkow, M.D. (4/21/05)
• Fiscal Year 2006 Budget Request to Senate Subcommittee - Statement of Nora D. Volkow, M.D. (4/6/05)
• Fiscal Year 2006 Budget Request to House Subcommittee - Statement of Nora D. Volkow, M.D. (3/9/05)
• Consequences of the Abuse of Anabolic Steroids - Before the Committee on Government Reform - Statement of Nora D. Volkow, M.D. (3/17/05)

Index for 2004

• Fiscal Year 2005 Budget Request to House Subcommittee - Statement of Nora D. Volkow, M.D. (4/29/04)
• Marijuana and Medicine: The Need for a Science-Based Approach - Statement of Nora D. Volkow, M.D. (4/1/04)
• Fiscal Year 2005 Budget Request to Senate Subcommittee - Statement of Nora D. Volkow, M.D. (4/1/04)
• Measuring The Effectiveness of Drug Addiction Treatment - Statement of Nora D. Volkow, M.D. (3/30/04)

• Fiscal Year 2004 Budget Request - Statement of Glen R. Hanson, Ph.D., D.D.S. (4/8/03)

Index for 2002

• Research on MDMA - Testimony Before the Subcommittee on Criminal Justice, Drug Policy and Human Resources - Statement of Glen R. Hanson, Ph.D., D.D.S. (9/19/02)
• Oversight Hearing on the Office of National Drug Control Policy's National Youth Anti-Drug Media Campaign - Statement of Wilson M. Compton, M.D, M.P.E. (6/20/02)
• Fiscal Year 2003 Budget Request - Statement of Glen R. Hanson, Ph.D., D.D.S. (3/13/02)
• "OxyContin: Balancing Risks and Benefits" - Hearing before the Health, Education, Labor, and Pensions Committee United States Senate (2/12/02)

• "Looking the Other Way: Rave Promoters and Club Drugs" - Hearing before the Senate Caucus on International Narcotics Control (12/4/01)
• Evaluation of the Office of National Drug Control Policy's (ONDCP's) National Youth Anti-Drug Media Campaign - Hearing Before the House Government Reform Subcommittee on Criminal Justice, Drug Policy and Human Resources (8/1/01)
• Ecstasy Abuse and Control - Hearing Before the Senate Subcommittee on Governmental Affairs (7/30/01)
• Continuing Concern over Imported Pharmaceuticals - Hearing Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives (6/7/01)
• Fiscal Year 2002 Budget Request - Statement of Alan I. Leshner, Ph.D. (5/16/01)
• "Treatment, Education, and Prevention - Adding to the Arsenal in the War on Drugs" - Hearing before the Senate Committee on the Judiciary (3/14/01).

Index for 2000

• Formal Statement for the Record on Club Drugs (MDMA, Ecstasy) by Alan I. Leshner, Ph.D. to the "U.S. Senate Caucus on International Narcotics Control"
• Statement of Alan I. Leshner, Ph.D. at the "Oversight Hearing on Programs of the Substance Abuse and Mental Health Services Administration (SAMHSA) and SAMHSA coordination with the National Institute on Drug Abuse"
• Statement of Alan I. Leshner, Ph.D. on Fiscal Year 2001 Budget Request

Index for 1999

• Statement of Alan I. Leshner, Ph.D. on Heroin Abuse and Addiction
• Statement of Alan I. Leshner, Ph.D. on The Drug Addiction Treatment Act of 1999
• Statement of Alan I. Leshner, Ph.D. on "Drug Legalization"
• Statement of Timothy P. Condon, Ph.D. on Science-Based Approaches to Preventing and Treating Heroin Abuse and Addiction
• Statement of Alan I. Leshner, Ph.D. at the Hearing on National Youth Anti-Drug Media
• Statement of Richard A. Millstein
• Statement by Stephen Zukin, M.D.
• Statement of Alan I. Leshner, Ph.D. on Fiscal Year 2000 Budget Request

Index for 1998

• Statement by James Cooper, M.D. on Methadone and the Treatment of Heroin Addiction
• Statement of Alan I. Leshner, Ph.D. on Fiscal Year 1999 Budget Request
• Statement of Alan I. Leshner, Ph.D. on Nicotine

Index for 1997

• Formal statement on Children Health Issues
• Formal statement

• 1998: Provision of Marijuana and Other Compounds For Scientific Research